CLINICAL ROLE -
Rates of Stroke in HIV Patients Highest Among Women
A proposed mechanism underlying observed sex differences in HIV-associated vascular risk is increased immune activation in women.
Hepatitis C Antiviral Drugs Reduce Liver Cancer Risk
Chronic infection with hepatitis C virus is the leading cause of hepatocellular carcinoma.
Adherence Levels Similar Between Branded, Generic HIV Drugs
There was no statistically significant difference in medication possession ratio among HIV-positive patients taking generic or branded antiretrovirals.
Direct-Acting Antivirals Reduce HCV-Related Cellular Changes
Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.
Self-Care Crucial for Patients with HIV
Health care professionals should provide resources that help patients with HIV practice self-care.
Spotlight on 'Informal' HIV Prevention Efforts
Pre-exposure prophylaxis is highly effective preventing HIV if used as prescribed.
Zinc May Improve Current Hepatitis C Therapies
Chronic HCV infection has been linked to low serum zinc and low metallothioneins expression in liver cells.
Hurdles to Treating HIV With Generic Drugs
Identifying and overcoming resistance to the use of generic HIV medications is becoming increasingly important to lower drug costs.
Treating Insulin Resistance in Hepatitis C-Infected Patients With Diabetes
Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.
Research Advances Towards Hepatitis C Vaccine
The path to a hepatitis C vaccine is yielded by the virusâ€™ virulent nature and its evasiveness to immune responses.
2 Clarke Drive Cranbury, NJ 08512